Duration of first off-treatment interval is prognostic for time to castration resistance and death in men with biochemical relapse of prostate cancer treated on a prospective trial of intermittent androgen deprivation. [electronic resource]
Producer: 20100721Description: 2668-73 p. digitalISSN:- 1527-7755
- Aged
- Aged, 80 and over
- Analysis of Variance
- Androgen Antagonists -- administration & dosage
- Antineoplastic Agents, Hormonal -- administration & dosage
- Brachytherapy -- methods
- Castration
- Cause of Death
- Chemotherapy, Adjuvant
- Confidence Intervals
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Drug Therapy, Combination
- Flutamide -- administration & dosage
- Follow-Up Studies
- Humans
- Immunohistochemistry
- Kaplan-Meier Estimate
- Leuprolide -- administration & dosage
- Male
- Middle Aged
- Multivariate Analysis
- Neoplasm Recurrence, Local -- drug therapy
- Neoplasm Staging
- Probability
- Prospective Studies
- Prostate-Specific Antigen -- blood
- Prostatectomy -- methods
- Prostatic Neoplasms -- mortality
- Risk Assessment
- Salvage Therapy -- methods
- Survival Analysis
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.